A detailed history of Graham Capital Management, L.P. transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 43,875 shares of EBS stock, worth $477,798. This represents 0.01% of its overall portfolio holdings.

Number of Shares
43,875
Holding current value
$477,798
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.86 - $6.98 $81,607 - $306,247
43,875 New
43,875 $299,000
Q4 2023

Feb 14, 2024

BUY
$1.82 - $3.16 $43,654 - $75,795
23,986 Added 189.6%
36,637 $87,000
Q3 2023

Nov 22, 2023

BUY
$3.17 - $7.91 $40,103 - $100,069
12,651 New
12,651 $43,000
Q2 2022

Aug 15, 2022

SELL
$27.42 - $43.63 $123,198 - $196,029
-4,493 Reduced 40.41%
6,626 $205,000
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $405,621 - $580,634
11,119 New
11,119 $456,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $543M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.